NICOLE LETENDRE: Open Payments
NPI 1003686528 · AUGUSTA, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$246 in 9 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $307 · 2025 $246
Food & beverage: $246
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 2 | $70 |
| GENZYME CORPORATION | 2 | $46 |
| Grifols USA, LLC | 2 | $42 |
| AstraZeneca Pharmaceuticals LP | 1 | $32 |
| Verona Pharma, Inc. | 1 | $32 |
| GlaxoSmithKline, LLC. | 1 | $24 |
Products named: DUPIXENT, Prolastin-C Liquid, FASENRA, Ohtuvayre, NUCALA.
Industry payments across ME — which companies pay providers there.
